Sage Therapeutics, Inc. Business Finance Contracts & Agreements

17 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
2014 Employee Stock Purchase Plan, as amended
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2023
2014 Employee Stock Purchase Plan, as amended
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2022
Underwriting Agreement, dated as of February 25, 2019, by and among Sage Therapeutics, Inc. and Goldman Sachs & Co. LLC. and J.P. Morgan Securities LLC
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2019
Underwriting Agreement, dated as of February 8, 2018, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as...
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2018
Underwriting Agreement, dated as of November 14, 2017, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as...
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2017
2014 Employee Stock Purchase Plan
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2017
SAGETHERAPEUTICS, INC. 4,402,515 Shares of Common Stock Underwriting Agreement (thisAgreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2016
SAGETHERAPEUTICS, INC. 3,157,894 Shares of Common Stock Underwriting Agreement (thisAgreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2016
SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2015
SAGE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 SUPPLY AGREEMENT
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
CA
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 Non-Exclusive...
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
CA
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 COMMERCIAL...
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
CA
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 EXCLUSIVE...
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
WA
2014
SAGE THERAPEUTICS, INC. 2011 STOCK OPTION AND GRANT PLAN
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2014
SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2014
SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2014